Cardiovascular Systems, Inc. Announces First Patient Enrolled in REACH PVI Clinical Study

66

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSIĀ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first patient was enrolled in the REACH PVI study. The purpose of this study is to prospectively evaluate acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease (PAD) in low ….

 

 

http://www.businesswire.com/news/home/20190611005836/en/Cardiovascular-Systems-Announces-Patient-Enrolled-REACH-PVI/